Alcohol interaction with metformin

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Metformin and Alcohol Interaction: Safety and Risk Considerations

Metformin is widely used to manage type 2 diabetes and is generally considered safe, but caution is advised when it is taken with alcohol. This is because both metformin and alcohol can independently increase the risk of lactic acidosis, a rare but serious condition. Therefore, patients are advised to be careful with alcohol consumption while on metformin, regardless of whether they have liver problems or not .

Metformin’s Effects on Alcohol-Induced Liver Injury

Research in animal models shows that metformin can actually protect the liver from alcohol-induced damage. In mice, metformin significantly reduced the buildup of fat in the liver and lessened liver inflammation caused by both acute and chronic alcohol exposure. This protective effect is linked to the drug’s ability to prevent the increase of a protein called plasminogen activator inhibitor-1 (PAI-1), which is associated with liver injury from alcohol .

Metformin and Alcohol Consumption Behavior

Studies in mice suggest that metformin may help reduce harmful, binge-like alcohol drinking. In experiments, metformin lowered alcohol intake in both male and female mice without affecting how quickly alcohol was cleared from their bodies. This points to the potential for metformin to be used as a treatment to help reduce excessive alcohol consumption .

Neuroprotective Effects of Metformin Against Alcohol Damage

Metformin also appears to protect the brain from alcohol-induced damage. In animal models of fetal alcohol spectrum disorders, metformin reduced inflammation, oxidative stress, and cell death in the brain. This suggests that metformin may help counteract some of the harmful effects of alcohol on the nervous system .

Metformin, Gut Microbiota, and Ethanol Production

Another area of research looks at how metformin affects gut bacteria that produce ethanol, especially in the context of non-alcoholic fatty liver disease (NAFLD). While metformin reduced the number of ethanol-producing bacteria in the gut, it did not significantly lower the total amount of ethanol produced. This means that the benefits of metformin in NAFLD are likely not due to changes in gut ethanol production .

Conclusion

In summary, while caution is needed when combining metformin and alcohol due to the risk of lactic acidosis, research shows that metformin may protect against alcohol-induced liver and brain damage and could even help reduce harmful drinking behaviors. However, its benefits in liver disease are not related to changes in gut ethanol production. Patients should always consult their healthcare provider about alcohol use while taking metformin Overend2012Bergheim2006Grigsby2024+2 MORE.

Sources and full results

Most relevant research papers on this topic

Metformin and alcohol

Metformin use is associated with reduced complications and mortality in type 2 diabetes patients, but caution is advised when concomitantly using alcohol, regardless of hepatic impairment restrictions.

Literature Review

2012·

1citation

·L. Overend et al.

Practical Diabetes·

DOI

Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1.

Metformin prevents alcohol-induced liver injury in mice by preventing the upregulation of plasminogen activator inhibitor-1, a key player in hepatic injury caused by ethanol.

Non-Randomized Exp.

2006·

204citations

·I. Bergheim et al.

Gastroenterology·

DOI

Effects of metformin on binge-like ethanol drinking and adenosine monophosphate kinase signaling in inbred High Drinking in the Dark - Line 1 mice

Metformin, an affordable and safe diabetes medication, can reduce binge-like ethanol intake in mice, potentially benefiting individuals with alcohol use disorder.

Non-Randomized Exp.

2024·

1citation

·Kolter B. Grigsby et al.

Alcohol, clinical & experimental research·

DOI

Anti-inflammatory, Antioxidant, and Antiapoptotic Action of Metformin Attenuates Ethanol Neurotoxicity in the Animal Model of Fetal Alcohol Spectrum Disorders

Metformin reduces ethanol-related neuroinflammation and apoptosis in the hippocampus of adult rats, offering potential neuroprotective effects.

Non-Randomized Exp.

2022·

26citations

·Maryam Sabzali et al.

Neurotoxicity Research·

DOI

Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic Fatty Liver Disease: Role of Metformin

Metformin does not significantly impact ethanol-producing gut bacteria, but may improve liver function and reduce inflammation in a mouse model of non-alcoholic fatty liver disease.

2023·

5citations

·Mohamed Abouelkheir et al.

Pharmaceuticals·

DOI

Metformin in non-alcoholic steatohepatitis.

Metformin treatment in non-alcoholic steatohepatitis (NASH) can reduce liver enzyme levels, but lactic acidosis and liver damage are risks, and strict adherence to prescribing guidelines is crucial.

2002·

324citations

·R. Urso et al.

Lancet·

DOI

Metformin in non-alcoholic steatohepatitis.

Metformin treatment significantly reduced liver volume and improved insulin sensitivity in non-alcoholic steatohepatitis patients, potentially offering a new treatment option.

2001·

414citations

·G. Marchesini et al.

Lancet·

DOI

Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats

The combination of metformin and malvidin effectively prevents non-alcoholic fatty liver disease progression in type 2 diabetes rats by improving lipid and glucose metabolisms and inhibiting inflammation.

RCTAnimalRigorous Journal

2021·

18citations

·Wen-Jun Zou et al.

Drug Design, Development and Therapy·

DOI

Hepatic exposure of metformin in patients with non‐alcoholic fatty liver disease

Metformin biodistribution to the liver in patients with non-alcoholic fatty liver disease is not significantly affected, suggesting its potential role in treating type 2 diabetes and reducing cardiovascular events.

Cross-Sectional StudyRigorous Journal

2019·

20citations

·E. Sundelin et al.

British Journal of Clinical Pharmacology·

DOI

Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis.

Metformin use in patients with nonalcoholic steatohepatitis and Child-Pugh A cirrhosis is associated with higher survival rates and lower rates of liver-related complications.

Cohort Study

2020·

65citations

·E. Vilar‐Gomez et al.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·

DOI

Try another search

lisinopril vs beta blockers

stellar observations with the Hubble Space Telescope

palliative care

climate change impacts

weight loss dietary interventions

vitamin C supplementation